Global Anti-Asthma Drugs Market is expected to grow at a CAGR of 5.94 % by 2022

Market Highlights

Market research future published a half-cooked research report on global anti-asthma drugs market. The global anti-asthma drugs market is expected to grow at a CAGR of 5.94 % during the period of 2015 to 2022.

Anti-asthma drugs are used for the treatment of asthma which is a disease of the airways resulting in narrowing and inflammation of air tubes, accompanied by increased secretion, swelling and build-up of tissue fluid characterized by symptoms such as tight chest, wheezing, cough and may be limitation of activity due to difficulty in breathing. As of 2015, almost 300 million people suffer from the disease and the numbers are rising which has been blamed primarily on rising pollution especially particulates.
The present market of anti-asthma drugs is valued at USD 18.9 billion in 2015 and is projected to grow to USD 28.3 billion in 2022 representing a CAGR of 5.94 %.

Test the market data and market information presented through more than 60 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Anti-asthma Drug Market Research Report - Forecast to 2022”.
The developed region anti-asthma drug market is flat and the key will be to tap the huge potential of developing region market. Thus market diversification will be of prime importance for growth. Another strategy will be development of novel biological anti-asthma drugs which is a drug class of future. Development of curative anti-asthma drug will be the single most important development and will make the first comer the leader till the patent expires. The uptake of any novel drug will be extremely fast with low marketing cost due to lack of any curative anti-asthma drug.

The market however is fragmented with a number of players and there is good penetration of generics. The loss of patents of some blockbusters such as Advair and Symbicort has numbed the market but these constraints are not enough to hold on for long. Thus taking all these factors together we expect a moderate growth potential of CAGR of 5.94%.

Request a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/2353

Major Key Players
• GlaxoSmithKline plc.,
• Merck & Co., Inc.,
• AstraZeneca plc.,
• F. Hoffmann-La Roche Ltd,
• Teva Pharmaceutical Industries,
• Novartis International AG,
• Boehringer Ingelheim,
• Sunovion Pharmaceuticals Inc.

Regional Analysis:
Depending on geographic region, Anti-asthma drug market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally developed countries led by North America is the largest market for Anti-asthma drugs. Europe is the second-largest market for anti-asthma drugs. The developing regions market such as Asia pacific region and Middle East & Africa however is rising much faster and will dominate in the near future.

Segmentation:
Global anti-asthma drugs market has been segmented on the basis of type (allergic (extrinsic) and non-allergic (intrinsic)), by trigger (child-onset, adult-onset, exercise-induced, cough-induced, occupational, nocturnal, steroid-resistant), by therapy (reliever treatment and maintenance treatment), by drug class (Bronchodilators (beta agonists, anti-cholinergics, xanthines), leukotriene antagonists, mast cell stabilizers, corticosteroids, monoclonal antibody) and by route of administration (oral, inhaled, intravenous, subcutaneous).

Access Report Details @ https://www.marketresearchfuture.com/reports/anti-asthma-drugs-market-2353

Brief TOC
6 Global anti-asthma drugs market, by trigger
6.1 Introduction
6.1.1 Child-onset asthma
6.1.2 Adult-onset asthma
6.1.3 Exercise-induced asthma
6.1.4 Cough-induced asthma
6.1.5 Occupational asthma
6.1.6 Nocturnal asthma
6.1.7 Steroid-resistant asthma
7 Global anti-asthma drugs market, by drug class
7.1 Introduction
7.1.1 Bronchodilators (beta agonists, anti-cholinergics, xanthines)
7.1.2 Leukotriene antagonists
7.1.3 Mast cell stabilizers
7.1.4 Corticosteroids
7.1.5 Monoclonal antibody
7.1.6 Others
8 Global anti-asthma drugs market, by therapy
8.1 Introduction
8.1.1 Preventive
8.1.2 Curative
Continued….

Browse Related Report
Asia-Pacific Glaucoma Treatment Market Information, by Disease Indication (Closed Angle Glaucoma (CAG), Open Angle Glaucoma (OAG), Secondary Glaucoma, Congenital Glaucoma and Other), Drug class (Prostaglandin Analogs (PGAs), Alpha Agonist, Beta Blockers, Cholinergic Drugs, Carbonic Anhydrase Inhibitors, and Others), Surgery (Laser Iridotomy, Laser Trabeculoplasty, Aqueous Shunt Surgery and Peripheral Iridectomy) and by End Users (Hospitals and Home Users) - Forecast till 2023

https://www.marketresearchfuture.com/reports/asia-pacific-glaucoma-treatment-market-2962

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.